Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting

被引：61

作者：

Sharifkashani, Sourena ^{[1
,2
]}

Bafrani, Melika Arab ^{[1
,3
]}

Khaboushan, Alireza Soltani ^{[1
,2
]}

Pirzadeh, Marzieh ^{[1
,4
]}

Kheirandish, Ali ^{[1
,5
]}

Bali, Hanie Yavarpour ^{[1
,4
]}

Hessami, Amirhossein ^{[1
,6
]}

Saghazadeh, Amene ^{[1
,7
]}

Rezaei, Nima ^{[7
,8
,9
]}

机构：

[1] Universal Sci Educ & Res Network USERN, Systemat Review & Meta Anal Expert Grp SRMEG, Tehran, Iran

[2] Univ Tehran Med Sci, Sch Med, Tehran, Iran

[3] Univ Tehran Med Sci, Students Sci Res Ctr SSRC, Tehran, Iran

[4] Babol Univ Med Sci, Student Res Comm, Babol, Iran

[5] Mazandaran Univ Med Sci, Sch Pharm, Student Res Comm, Sari, Iran

[6] Mazandaran Univ Med Sci, Sch Med, Student Res Comm, Sari, Iran

[7] Univ Tehran Med Sci, Res Ctr Immunodeficiencies, Childrens Med Ctr, Tehran, Iran

[8] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran

[9] Universal Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun NIIMA, Tehran, Iran

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 2020年 / 884卷

关键词：

ACE2; COVID-19; SARS-CoV2; Origin; Therapeutic; Transmission; CORONAVIRUS SPIKE PROTEIN; EXPRESSION; COVID-19; SERINE; PREVENTION; TMPRSS2; ORIGIN;

D O I：

10.1016/j.ejphar.2020.173455

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus that uses the human angiotensin-converting enzyme 2 (ACE2) receptor as a point of entry. The present review discusses the origin and structure of the virus and its mechanism of cell entry followed by the therapeutic potentials of strategies directed towards SARS-CoV2-ACE2 binding, the renin-angiotensin system, and the kinin-kallikrein system. SARS-CoV2-ACE2 binding-directed approaches mainly consist of targeting receptor binding domain, ACE2 blockers, soluble ACE2, and host protease inhibitors. In conclusion, blocking or manipulating the SARS-CoV2-ACE2 binding interface perhaps offers the best tactic against the virus that should be treated as a fundamental subject of future research.

引用

收藏

页数：6

相关论文

共 50 条

[41] Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies [J].

Papavassiliou, Kostas A. ;

Gogou, Vassiliki A. ;

Papavassiliou, Athanasios G. .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)

[42] SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 Receptor: Angiotensin-Converting Enzyme Inhibitor/Angiotensin 2 Receptor Blocker Utilization and a Shift Towards the Renin-Angiotensin-Aldosterone System Classical Pathway [J].

Felber, Randy ;

New, William ;

Riskin, Suzanne I. .

CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)

[43] Is targeting angiotensin-converting enzyme 2 (ACE2) a prophylactic strategy against COVID-19? [J].

Li, Jing ;

Yan, Yufen ;

Dou, Fangzhou ;

Gao, Jianjun .

BIOSCIENCE TRENDS, 2022, 16 (06) :459-461

[44] Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS) [J].

Cadegiani, Flavio A. ;

Goren, Andy ;

Wambier, Carlos G. .

MEDICAL HYPOTHESES, 2020, 143

[45] Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection [J].

Alabsi, Sarah ;

Dhole, Atharva ;

Hozayen, Sameh ;

Chapman, Scott A. .

MICROORGANISMS, 2023, 11 (03)

[46] Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 [J].

Ni, Wentao ;

Yang, Xiuwen ;

Yang, Deqing ;

Bao, Jing ;

Li, Ran ;

Xiao, Yongjiu ;

Hou, Chang ;

Wang, Haibin ;

Liu, Jie ;

Yang, Donghong ;

Xu, Yu ;

Cao, Zhaolong ;

Gao, Zhancheng .

CRITICAL CARE, 2020, 24 (01)

[47] Characterizations of angiotensin-converting enzyme-2 (ACE2) peptidase activity [J].

Saulnier, Nathalie M. ;

Thorne, Devyn M. ;

Bablu, Fariha E. ;

Suzuki, Alessia M. ;

Khan, Rafa L. ;

Oliveira, Katelin X. ;

Suzuki, Yuichiro J. .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 761

[48] Design of Inhibitory Peptides of the Interaction between the RBD Domain of the S1 Protein of SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 (ACE2) Receptor [J].

Andres Rodriguez-Salazar, Carlos ;

Piedad Recalde-Reyes, Delia ;

Carlos Castano-Osorio, Jhon .

LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (07) :666-673

[49] Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells [J].

Kumar, K. J. Senthil ;

Vani, M. Gokila ;

Wang, Chung-Shuan ;

Chen, Chia-Chi ;

Chen, Yu-Chien ;

Lu, Li-Ping ;

Huang, Ching-Hsiang ;

Lai, Chien-Sing ;

Wang, Sheng-Yang .

PLANTS-BASEL, 2020, 9 (06) :1-12

[50] Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19 [J].

Fu, Jiewen ;

Zhou, Baixu ;

Zhang, Lianmei ;

Balaji, Kyathegowdanadoddi Srinivasa ;

Wei, Chunli ;

Liu, Xiaoyan ;

Chen, Hanchun ;

Peng, Jiangzhou ;

Fu, Junjiang .

MOLECULAR BIOLOGY REPORTS, 2020, 47 (06) :4383-4392

← 1 2 3 4 5 →